Early research (Phase 1)WithdrawnNCT06124118What this trial is testingTumor Treating Fields for Locally Advanced NSCLCWho this might be right forNon Small Cell Lung Cancer University of Utah
Large-scale testing (Phase 3)Not Yet RecruitingNCT07376382What this trial is testingA Phase Ⅲ Clinical Study of SYS6010 in Combination With Osimertinib in Patients With Locally Advanced or Metastatic NSCLCWho this might be right forNSCLC CSPC Megalith Biopharmaceutical Co.,Ltd. 680
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Large-scale testing (Phase 3)UnknownNCT00022009What this trial is testingGemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forLung Cancer The Christie NHS Foundation Trust
Testing effectiveness (Phase 2)Study completedNCT04905316What this trial is testingCanakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung CancerWho this might be right forNon-small Cell Lung Cancer Memorial Sloan Kettering Cancer Center 41
Testing effectiveness (Phase 2)Looking for participantsNCT06244771What this trial is testingA Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid TumorsWho this might be right forAdvanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more Frontier Medicines Corporation 403
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299What this trial is testingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07759492What this trial is testingPersonnalized Immunotherapy in Patients With Stage III Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Stage III Unresectable Intergroupe Francophone de Cancerologie Thoracique 177
Testing effectiveness (Phase 2)Active Not RecruitingNCT05949606What this trial is testingSI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Sichuan Baili Pharmaceutical Co., Ltd. 95
Testing effectiveness (Phase 2)Looking for participantsNCT06755684What this trial is testingNeoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung CancerWho this might be right forEGFRNon-Small Cell Lung CancerLocally Advanced Non-Small Cell Lung Cancer+5 more Peng Zhang 60
Large-scale testing (Phase 3)Looking for participantsNCT07662395What this trial is testingSCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung CancerWho this might be right forDouble Blind Sinocelltech Ltd. 410
Large-scale testing (Phase 3)Not Yet RecruitingNCT07756645What this trial is testingAssess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult ParticipantsWho this might be right forNon-Small Cell Lung Cancer AbbVie 940
Testing effectiveness (Phase 2)Active Not RecruitingNCT05712902What this trial is testingSunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)Who this might be right forNon-Small Cell Lung Cancer Dizal Pharmaceuticals 104
Post-approval studies (Phase 4)UnknownNCT04814056What this trial is testingTo Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 FusionWho this might be right forNRG1-fused Non-small Cell Lung Cancer Shanghai Chest Hospital 15
Large-scale testing (Phase 3)Active Not RecruitingNCT05870319What this trial is testingA Phase III Study of SKB264 for EGFR Mutant NSCLC PatientsWho this might be right forNon-small Cell Lung Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Large-scale testing (Phase 3)Active Not RecruitingNCT05690945What this trial is testingQL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung CancerWho this might be right forLung Cancer Qilu Pharmaceutical Co., Ltd. 606
Early research (Phase 1)Study completedNCT00773188What this trial is testingA Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.Who this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 6
Not applicableUnknownNCT05641870What this trial is testingMolecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLCWho this might be right forLung CancerStage III Lung CancerUnresectable Lung Carcinoma Parc de Salut Mar 80
Testing effectiveness (Phase 2)UnknownNCT01054482What this trial is testingPre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer The First Affiliated Hospital of Guangzhou Medical University 120
Testing effectiveness (Phase 2)Study completedNCT00550173What this trial is testingNon-Smoker Patients With Nonsquamous Non-Small Cell Lung CancerWho this might be right forNon-Small-Cell Lung Cancer Eli Lilly and Company 247